A detailed history of Yousif Capital Management, LLC transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Yousif Capital Management, LLC holds 11,703 shares of HRMY stock, worth $406,211. This represents 0.01% of its overall portfolio holdings.

Number of Shares
11,703
Previous 12,912 9.36%
Holding current value
$406,211
Previous $389,000 20.05%
% of portfolio
0.01%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

SELL
$30.0 - $39.95 $36,270 - $48,299
-1,209 Reduced 9.36%
11,703 $467,000
Q2 2024

Jul 31, 2024

SELL
$28.81 - $33.01 $58,801 - $67,373
-2,041 Reduced 13.65%
12,912 $389,000
Q1 2024

Apr 26, 2024

SELL
$29.93 - $35.06 $42,051 - $49,259
-1,405 Reduced 8.59%
14,953 $502,000
Q4 2023

Feb 01, 2024

SELL
$19.2 - $33.78 $6,240 - $10,978
-325 Reduced 1.95%
16,358 $528,000
Q3 2023

Oct 30, 2023

BUY
$31.89 - $39.03 $22,992 - $28,140
721 Added 4.52%
16,683 $546,000
Q2 2023

Aug 02, 2023

SELL
$30.5 - $37.4 $25,345 - $31,079
-831 Reduced 4.95%
15,962 $561,000
Q1 2023

May 02, 2023

SELL
$30.8 - $53.92 $67,760 - $118,624
-2,200 Reduced 11.58%
16,793 $548,000
Q4 2022

Jan 09, 2023

SELL
$45.4 - $60.91 $222,006 - $297,849
-4,890 Reduced 20.47%
18,993 $0
Q3 2022

Nov 04, 2022

BUY
$42.06 - $55.45 $207,944 - $274,144
4,944 Added 26.1%
23,883 $1.06 Million
Q2 2022

Aug 01, 2022

SELL
$33.54 - $52.15 $65,067 - $101,171
-1,940 Reduced 9.29%
18,939 $924,000
Q1 2022

May 12, 2022

BUY
$33.14 - $51.13 $23,529 - $36,302
710 Added 3.52%
20,879 $1.02 Million
Q4 2021

Jan 31, 2022

BUY
$34.09 - $43.91 $687,561 - $885,620
20,169 New
20,169 $860,000

Others Institutions Holding HRMY

About Harmony Biosciences Holdings, Inc.


  • Ticker HRMY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,161,400
  • Market Cap $2.05B
  • Description
  • Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...
More about HRMY
Track This Portfolio

Track Yousif Capital Management, LLC Portfolio

Follow Yousif Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Yousif Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Yousif Capital Management, LLC with notifications on news.